Recent publications
Article
Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (Courage-PD) Consortium, Domenighetti, C, Sugier, P-E, Ashok Kumar Sreelatha, A, Schulte, C, Grover, S, Mohamed, O, Portugal, B, May, P, Bobbili, DR, Radivojkov-Blagojevic, M, Lichtner, P, Singleton, AB, Hernandez, DG, Edsall, C, Mellick, GD, Zimprich, A, Pirker, W, Rogaeva, E, Lang, AE, Koks, S, Taba, P, Lesage, S, Brice, A, Corvol, J-C, Chartier-Harlin, M-C, Mutez, E, Brockmann, K, Deutschländer, AB, Hadjigeorgiou, GM, Dardiotis, E, Stefanis, L, Simitsi, AM, Valente, EM, Petrucci, S, Duga, S, Straniero, L, Zecchinelli, A, Pezzoli, G, Brighina, L, Ferrarese, C, Annesi, G, Quattrone, A, Gagliardi, M, Matsuo, H, Kawamura, Y, Hattori, N, Nishioka, K, Chung, SJ, Kim, YJ & Clarke, CE 2022, 'Dairy intake and Parkinson's disease: a mendelian randomization study', Movement Disorders. https://doi.org/10.1002/mds.28902
PD Med Collaborative Group 2021, 'Cost-effectiveness of dopamine agonists and monoamine oxidase B inhibitors in early Parkinson's disease', Movement Disorders. https://doi.org/10.1002/mds.28623
Scobie , S, Jowett, S, Lambe, T, Patel, S, Woolley, R, Rowland, N, Rick, C, Smith, C, Brady , M, Clarke, CE & Sackley, C 2021, 'Lee Silverman voice treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial', Pilot and Feasibility Studies, vol. 7, no. 1, 154. https://doi.org/10.1186/s40814-021-00888-y
Gray, R, Patel, S, Rowland, N, Rick, C, Woolley, R, Muzerengi, S, Gray, A, Jenkinson, C, McIntosh, E, Wheatley, K, Williams, A, Clarke, CE & PD Med Collaborative Group 2021, 'Long-term effectiveness of adjuvant treatment with catechol-O-methyltransferase or monoamine oxidase B inhibitors compared with dopamine agonists among patients with Parkinson disease uncontrolled by Levodopa Therapy: the PD MED randomized clinical trial', JAMA Neurology. https://doi.org/10.1001/jamaneurol.2021.4736
Comprehensive Unbiaised Risk Factor Assessment for Genetics and Environment in Parkinson’s Disease (Courage-PD) consortium 2021, 'Mendelian randomisation study of smoking, alcohol, and coffee drinking in relation to Parkinson's disease', Journal of Parkinson's Disease. https://doi.org/10.3233/JPD-212851
Sackley, C, Rick, C, Au, P, Brady , MC, Beaton , G, Burton, C, Caulfield, M, Dickson , S, Dowling, F, Hughes, M, Rowland, N, Jowett, S, Masterson-Algar, P, Nicoll , A, Patel, S, Smith , CH, Woolley, R & Clarke, CE 2020, 'A multi-centre randomised controlled trial to compare the clinical and cost effectiveness of Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial', Trials, vol. 21, no. 1, 436. https://doi.org/10.1186/s13063-020-04354-7
Lang, AE, de Bie, RMA, Clarke, CE, Espay, AJ & Fox, SH 2020, 'Initiating pharmacotherapy in early Parkinson's disease', The Lancet Neurology, vol. 19, no. 8, pp. 643-644. https://doi.org/10.1016/S1474-4422(20)30225-8
Herd, C, Tomlinson, C, Rick, C, Scotton, W, Edwards, J, Ives, N, Clarke, CE & Sinclair, A 2019, 'Cochrane systematic review and meta-analysis of Botulinum toxin for the prevention of migraine', BMJ open, vol. 9, no. 7, e027953. https://doi.org/10.1136/bmjopen-2018-027953
Smith, CH, Patel, S, Woolley, RL, Brady, MC, Rick, CE, Halfpenny, R, Rontiris, A, Knox-Smith, L, Dowling, F, Clarke, CE, Au, P, Ives, N, Wheatley, K & Sackley, CM 2019, 'Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listeners', Clinical Linguistics & Phonetics, vol. 33, no. 10-11, pp. 1063-1070. https://doi.org/10.1080/02699206.2019.1604806
American Genome Center 2019, 'The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight', Movement Disorders, vol. 34, no. 12, pp. 1851-1863. https://doi.org/10.1002/mds.27864
Herd, C, Cl, T, Rick, C, Scotton, WJ, Edwards, J, Ives, N, Clarke, CE & Sinclair, A 2018, 'Botulinum toxins for the prevention of migraine in adults', Cochrane Database of Systematic Reviews, no. 6, CD011616. https://doi.org/10.1002/14651858.CD011616.pub2
Sackley, CM, Smith, CH, Rick, C, Brady, MC, Ives, N, Patel, S, Woolley, R, Dowling, F, Patel, R, Roberts, H, Jowett, S, Wheatley, K, Kelly, D, Sands, G, Clarke, CE & PD COMM Pilot Collaborative Group 2018, 'Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson’s disease: a pilot randomised controlled trial (PD COMM pilot)', Pilot and Feasibility Studies, vol. 4, no. 30. https://doi.org/10.1186/s40814-017-0222-z
Muzerengi, S, Rick, C, Begaj, I, Ives, N, Evison, F, Woolley, RL & Clarke, CE 2017, 'Coding accuracy for Parkinson's disease hospital admissions: implications for healthcare planning in the UK', Public Health, vol. 146, pp. 4-9. https://doi.org/10.1016/j.puhe.2016.12.024
Review article
de Bie, RMA, Clarke, CE, Espay, AJ, Fox, SH & Lang, AE 2020, 'Initiation of pharmacological therapy in Parkinson's disease: when, why, and how', The Lancet Neurology, vol. 19, no. 5, pp. 452-461. https://doi.org/10.1016/S1474-4422(20)30036-3
Herd, CP, Tomlinson, CL, Rick, C, Scotton, WJ, Edwards, J, Ives, N, Clarke, CE & Sinclair, A 2018, 'Botulinum toxins for the prevention of migraine in adults', Cochrane Database of Systematic Reviews, vol. 6, CD011616. https://doi.org/10.1002/14651858.CD011616.pub2
View all publications in research portal